Koers Kelyniam Global, Inc. Other OTC
Aandelen
KLYG
US4883591004
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 3,02 mln. 2,78 mln. | Omzet 2023 | 2,67 mln. 2,46 mln. | Marktkapitalisatie | 1,83 mln. 1,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 0,99 x |
Nettoschuld 2022 | 560K 516K | Nettoschuld 2023 | 623K 574K | EV/omzet 2023 | 0,92 x |
K/w-verhouding 2022 |
-24,8
x | K/w-verhouding 2023 |
-8,35
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 53,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 09-01-18 |
Director of Finance/CFO | - | 01-02-20 | |
Chief Operating Officer | - | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Operating Officer | - | 01-01-11 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 01-06-14 |
Ross Bjella
CEO | Chief Executive Officer | - | 09-01-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,03% | 223 mld. | |
+13,59% | 195 mld. | |
+20,01% | 144 mld. | |
+30,83% | 111 mld. | |
+2,05% | 65,01 mld. | |
+15,38% | 53,02 mld. | |
+3,96% | 50,45 mld. | |
+8,37% | 44,15 mld. | |
+3,27% | 36,45 mld. |